-
Je něco špatně v tomto záznamu ?
Chronic exposure of bumblebees to neonicotinoid imidacloprid suppresses the entire mevalonate pathway and fatty acid synthesis
T. Erban, B. Sopko, P. Talacko, K. Harant, K. Kadlikova, T. Halesova, K. Riddellova, A. Pekas,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- dusíkaté sloučeniny farmakologie MeSH
- insekticidy farmakologie MeSH
- kyselina mevalonová metabolismus MeSH
- mastné kyseliny biosyntéza MeSH
- neonikotinoidy farmakologie MeSH
- včely metabolismus MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Determining the side effects of pesticides on pollinators is an important topic due to the increasing loss of pollinators. We aimed to determine the effects of chronic sublethal exposure of the neonicotinoid pesticide imidacloprid on the bumblebee Bombus terrestris under laboratory conditions. The analytical standard of imidacloprid in sugar solution was used for the treatment. Verification of pesticides using UHPLC-QqQ-MS/MS in the experimental bumblebees showed the presence of only two compounds, imidacloprid and imidacloprid-olefin, which were found in quantities of 0.57 ± 0.22 and 1.95 ± 0.43 ng/g, respectively. Thus, the level of the dangerous metabolite imidacloprid-olefin was 3.4-fold higher than that of imidacloprid. Label-free nanoLC-MS/MS quantitative proteomics of bumblebee heads enabled quantitative comparison of 2883 proteins, and 206 proteins were significantly influenced by the imidacloprid treatment. The next analysis revealed that the highly downregulated markers are members of the terpenoid backbone biosynthesis pathway (KEGG: bter00900) and that imidacloprid treatment suppressed the entire mevalonate pathway, fatty acid synthesis and associated markers. The proteomics results indicate that the consequences of imidacloprid treatment are complex, and the marker changes are associated with metabolic and neurological diseases and olfaction disruption. This study provides important markers and can help to explain the widely held assumptions from biological observations. SIGNIFICANCE: The major finding is that all markers of the mevalonate pathway were substantially downregulated due to the chronic imidacloprid exposure. The disbalance of mevalonate pathway has many important consequences. We suggest the mechanism associated with the novel toxicogenic effect of imidacloprid. The results are helpful to explain that imidacloprid impairs the cognitive functions and possesses the delayed and time cumulative effect.
ALS Limited ALS Czech Republic Na Harfe 336 9 Prague CZ 190 00 Czechia
Crop Research Institute Drnovska 507 73 Prague CZ 161 06 Czechia
Proteomics Core Facility Faculty of Science Charles University Prague Czechia
R and D Department Biobest Group Ilse Velden 18 Westerlo B 2260 Belgium
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20022827
- 003
- CZ-PrNML
- 005
- 20211011085620.0
- 007
- ta
- 008
- 201125s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jprot.2018.12.022 $2 doi
- 035 __
- $a (PubMed)30583045
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Erban, Tomáš, $d 1978- $u Crop Research Institute, Drnovska 507/73, Prague CZ-161 06, Czechia. Electronic address: arachnid@centrum.cz. $7 mzk2005306687
- 245 10
- $a Chronic exposure of bumblebees to neonicotinoid imidacloprid suppresses the entire mevalonate pathway and fatty acid synthesis / $c T. Erban, B. Sopko, P. Talacko, K. Harant, K. Kadlikova, T. Halesova, K. Riddellova, A. Pekas,
- 520 9_
- $a Determining the side effects of pesticides on pollinators is an important topic due to the increasing loss of pollinators. We aimed to determine the effects of chronic sublethal exposure of the neonicotinoid pesticide imidacloprid on the bumblebee Bombus terrestris under laboratory conditions. The analytical standard of imidacloprid in sugar solution was used for the treatment. Verification of pesticides using UHPLC-QqQ-MS/MS in the experimental bumblebees showed the presence of only two compounds, imidacloprid and imidacloprid-olefin, which were found in quantities of 0.57 ± 0.22 and 1.95 ± 0.43 ng/g, respectively. Thus, the level of the dangerous metabolite imidacloprid-olefin was 3.4-fold higher than that of imidacloprid. Label-free nanoLC-MS/MS quantitative proteomics of bumblebee heads enabled quantitative comparison of 2883 proteins, and 206 proteins were significantly influenced by the imidacloprid treatment. The next analysis revealed that the highly downregulated markers are members of the terpenoid backbone biosynthesis pathway (KEGG: bter00900) and that imidacloprid treatment suppressed the entire mevalonate pathway, fatty acid synthesis and associated markers. The proteomics results indicate that the consequences of imidacloprid treatment are complex, and the marker changes are associated with metabolic and neurological diseases and olfaction disruption. This study provides important markers and can help to explain the widely held assumptions from biological observations. SIGNIFICANCE: The major finding is that all markers of the mevalonate pathway were substantially downregulated due to the chronic imidacloprid exposure. The disbalance of mevalonate pathway has many important consequences. We suggest the mechanism associated with the novel toxicogenic effect of imidacloprid. The results are helpful to explain that imidacloprid impairs the cognitive functions and possesses the delayed and time cumulative effect.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a včely $x metabolismus $7 D001516
- 650 _2
- $a mastné kyseliny $x biosyntéza $7 D005227
- 650 _2
- $a insekticidy $x farmakologie $7 D007306
- 650 _2
- $a kyselina mevalonová $x metabolismus $7 D008798
- 650 _2
- $a neonikotinoidy $x farmakologie $7 D000073943
- 650 _2
- $a dusíkaté sloučeniny $x farmakologie $7 D009574
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sopko, Bruno $u Crop Research Institute, Drnovska 507/73, Prague CZ-161 06, Czechia; Department of Medical Chemistry and Clinical Biochemistry, Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84/1, Prague CZ-150 06, Czechia. $7 xx0250670
- 700 1_
- $a Talacko, Pavel, $u Proteomics Core Facility, Faculty of Science, Charles University, Prague, Czechia. $d 1987- $7 xx0264710
- 700 1_
- $a Harant, Karel $u Proteomics Core Facility, Faculty of Science, Charles University, Prague, Czechia.
- 700 1_
- $a Kadlíková, Klára $u Crop Research Institute, Drnovska 507/73, Prague CZ-161 06, Czechia; Department of Plant Protection, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, Prague 6, Suchdol CZ-165 00, Czechia. $7 xx0250559
- 700 1_
- $a Halešová, Taťána $u ALS Limited, ALS Czech Republic, Na Harfe 336/9, Prague CZ-190 00, Czechia. $7 xx0250555
- 700 1_
- $a Riddellova, Katerina $u ALS Limited, ALS Czech Republic, Na Harfe 336/9, Prague CZ-190 00, Czechia.
- 700 1_
- $a Pekas, Apostolos $u R&D Department, Biobest Group, Ilse Velden 18, Westerlo B-2260, Belgium.
- 773 0_
- $w MED00166847 $t Journal of proteomics $x 1876-7737 $g Roč. 196, č. - (2019), s. 69-80
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30583045 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20211011085621 $b ABA008
- 999 __
- $a ok $b bmc $g 1595146 $s 1113503
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 196 $c - $d 69-80 $e 20181221 $i 1876-7737 $m Journal of proteomics $n J Proteomics $x MED00166847
- LZP __
- $a Pubmed-20201125